National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 32006 [2017-14433]
Download as PDF
32006
Federal Register / Vol. 82, No. 131 / Tuesday, July 11, 2017 / Notices
instruments must be requested in
writing.
Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires: written
comments and/or suggestions from the
public and affected agencies are invited
to address one or more of the following
points: (1) Whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
SUPPLEMENTARY INFORMATION:
Proposed Collection Title: The
National Institute of Mental Health Data
Archive (NDA), REVISION, OMB
Control Number 0925–0667, National
Institute of Mental Health (NIMH),
National Institutes of Health (NIH).
Need and Use of Information
Collection: This REVISION request
seeks approval of updates to the
previously approved National Database
for Autism Research Data Access
Request and Data Use Certification
documents. The NIMH Data Archive
(NDA), formerly known as the National
Database for Autism Research (NDAR),
is an infrastructure that allows for the
submission and storage of human
subjects data from researchers
conducting studies related to many
scientific domains, regardless of the
source of funding. The NIH and NIMH
developed this resource to allow for the
public collection of information from:
(1) Individuals who seek permission to
access data from the NDA for the
purpose of scientific investigation,
scholarship or teaching, or other forms
of research and research development,
via the Data Use Certification (DUC),
and (2) individuals who request
permission to submit data to the NDA
for the purpose of scientific
investigation, scholarship or teaching,
or other forms of research and research
development, via the Data Submission
Agreement (DSA). The extensive
information stored in the NDA
continues to provide a rare and valuable
scientific resource to the field, and plays
an integral part in fulfilling research
objectives in multiple scientific
domains. The NIH and the NIMH seek
to encourage use of the NDA by
investigators in the field of multiple
scientific research domains to achieve
rapid scientific progress. In order to take
full advantage of this resource and
maximize its research value, it is
important that data are made broadly
available, on appropriate terms and
conditions, to the largest possible
number of investigators.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1000.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Average
burden per
response
(in hours)
Number of
responses per
respondent
Total annual
burden hours
Form name
Type of respondents
NDA Data Submission Agreement
(DSA).
NDA Data Use Certification (DUC)
Researchers submitting data .........
250
1
1 hour .................
250
Researchers requesting access to
data.
750
1
1 hour .................
750
Total .........................................
........................................................
1000
1000
............................
1000
Melba Rojas,
Project Clearance Liaison, National Institute
of Mental Health, National Institutes of
Health.
[FR Doc. 2017–14451 Filed 7–10–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK30JT082PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
VerDate Sep<11>2014
18:01 Jul 10, 2017
Jkt 241001
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; T Cell Reagent Resource for
the Study of Allergic Diseases (U19).
Date: August 1–2, 2017.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Thomas F. Conway, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
Room 3G51, National Institutes of Health,
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20892–9823, 240–507–9685,
thomas.conway@nih.gov.
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: July 5, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–14433 Filed 7–10–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
E:\FR\FM\11JYN1.SGM
11JYN1
Agencies
[Federal Register Volume 82, Number 131 (Tuesday, July 11, 2017)]
[Notices]
[Page 32006]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-14433]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; T Cell Reagent Resource for the
Study of Allergic Diseases (U19).
Date: August 1-2, 2017.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Thomas F. Conway, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G51, National Institutes of Health, NIAID, 5601
Fishers Lane, MSC 9823, Bethesda, MD 20892-9823, 240-507-9685,
thomas.conway@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: July 5, 2017.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-14433 Filed 7-10-17; 8:45 am]
BILLING CODE 4140-01-P